Literature DB >> 29337070

Intrinsic and extrinsic contributors to defective CD8+ T cell responses with aging.

Mladen Jergović1, Megan J Smithey2, Janko Nikolich-Žugich3.   

Abstract

Aging has a profound effect on the immune system, and both innate and adaptive arms of the immune system show functional decline with age. In response to infection with intracellular microorganisms, old animals mobilize decreased numbers of antigen-specific CD8+ T cells with reduced production of effector molecules and impaired cytolytic activity. However, the CD8+ T cell-intrinsic contribution to, and molecular mechanisms behind, these defects remain unclear. In this review we will discuss the mechanistic contributions of age related changes in the CD8+ T cell pool and the relative roles of intrinsic functional defects in aged CD8+ T cells vs. defects in the aged environment initiating the CD8+ T cell response.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29337070     DOI: 10.1016/j.exger.2018.01.011

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  15 in total

1.  Do cytomegalovirus-specific memory T cells interfere with new immune responses in lymphoid tissues?

Authors:  Mladen Jergović; Jennifer L Uhrlaub; Nico A Contreras; Janko Nikolich-Žugich
Journal:  Geroscience       Date:  2019-05-08       Impact factor: 7.713

Review 2.  Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?

Authors:  Niharika A Duggal; Grace Niemiro; Stephen D R Harridge; Richard J Simpson; Janet M Lord
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

3.  Testosterone treatment of aged male mice improves some but not all aspects of age-associated increases in influenza severity.

Authors:  Landon G Vom Steeg; Sarah E Attreed; Barry Zirkin; Sabra L Klein
Journal:  Cell Immunol       Date:  2019-09-14       Impact factor: 4.868

Review 4.  Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.

Authors:  Elizabeth A Mills; Yang Mao-Draayer
Journal:  Mult Scler       Date:  2018-05-18       Impact factor: 6.312

Review 5.  The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  J Neuroinflammation       Date:  2021-03-22       Impact factor: 8.322

6.  Bone Marrow Plasma Cells Modulate Local Myeloid-Lineage Differentiation via IL-10.

Authors:  Lingzhang Meng; Larissa Nogueira Almeida; Ann-Katrin Clauder; Timo Lindemann; Julia Luther; Christopher Link; Katharina Hofmann; Upasana Kulkarni; David Ming Wong; Jean-Pierre David; Rudolf Armin Manz
Journal:  Front Immunol       Date:  2019-05-31       Impact factor: 7.561

Review 7.  Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.

Authors:  Angelika Wagner; Birgit Weinberger
Journal:  Front Immunol       Date:  2020-04-23       Impact factor: 7.561

8.  Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia.

Authors:  Nick P Goplen; Yue Wu; Young Min Son; Chaofan Li; Zheng Wang; In Su Cheon; Li Jiang; Bibo Zhu; Katayoun Ayasoufi; Eduardo N Chini; Aaron J Johnson; Robert Vassallo; Andrew H Limper; Nu Zhang; Jie Sun
Journal:  Sci Immunol       Date:  2020-11-06

9.  Defective Transcriptional Programming of Effector CD8 T Cells in Aged Mice Is Cell-Extrinsic and Can Be Corrected by Administration of IL-12 and IL-18.

Authors:  Mladen Jergović; Heather L Thompson; Kristin R Renkema; Megan J Smithey; Janko Nikolich-Žugich
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

10.  Intrinsically altered lung-resident γδT cells control lung melanoma by producing interleukin-17A in the elderly.

Authors:  Min Cheng; Yongyan Chen; Dake Huang; Wen Chen; Weiping Xu; Yin Chen; Guodong Shen; Tingjuan Xu; Gan Shen; Zhigang Tian; Shilian Hu
Journal:  Aging Cell       Date:  2020-01-05       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.